Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects.
Author: Akanji AO, Ohaeri JU, Al Shammri SA, Fatania HR.
Source:
Clinical Chemistry and Laboratory Medicine (CCLM), 45(9), 1229-1231.
BACKGROUND: Insulin-like growth factors (IGFs) are believed to be important in
brain development and repair following neuronal damage. It is also speculated
that IGFs are involved in the association of foetal and pre-adult growth with
schizophrenia (SZ). METHODS: The aim of this study was to assess levels of IGF-I,
IGF-II and IGF binding protein (IGFBP)-3 and their associations in male Arab
patients with SZ (n=53) and healthy control subjects (HC; n=52). Anthropometric
and demographic data were collected for each subject for whom blood specimens
were analysed for serum lipoproteins, apolipoprotein B (apoB), IGF-I, IGF-II and
IGFBP-3. RESULTS: The SZ group had lower serum total cholesterol, apoB and uric
acid levels than the HC group (p<0.05). IGF-II levels were significantly higher
in the SZ group (p=0.02) and correlated positively with levels of atherogenic
lipoproteins--total cholesterol, low-density lipoprotein, apoB--and IGFBP-3. The
pattern of correlations between the IGFs and the various parameters differed
somewhat between the HC and SZ groups. CONCLUSIONS: These results demonstrate
that IGF-II levels are increased in patients with SZ and show significant
associations with atherogenic lipoproteins. We suggest a possible link between
IGF-II metabolism and atherogenesis in SZ